134 related articles for article (PubMed ID: 26703564)
21. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.
Wang CS; Lin KH; Chen SL; Chan YF; Hsueh S
Br J Cancer; 2004 Nov; 91(11):1924-30. PubMed ID: 15558074
[TBL] [Abstract][Full Text] [Related]
22. Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis.
Pavlovic M; Arnal-Estapé A; Rojo F; Bellmunt A; Tarragona M; Guiu M; Planet E; Garcia-Albéniz X; Morales M; Urosevic J; Gawrzak S; Rovira A; Prat A; Nonell L; Lluch A; Jean-Mairet J; Coleman R; Albanell J; Gomis RR
J Natl Cancer Inst; 2015 Dec; 107(12):djv256. PubMed ID: 26376684
[TBL] [Abstract][Full Text] [Related]
23. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
[TBL] [Abstract][Full Text] [Related]
24. Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.
España L; Martín B; Aragüés R; Chiva C; Oliva B; Andreu D; Sierra A
Am J Pathol; 2005 Oct; 167(4):1125-37. PubMed ID: 16192647
[TBL] [Abstract][Full Text] [Related]
25. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
Koukourakis MI; Giatromanolaki A; Brekken RA; Sivridis E; Gatter KC; Harris AL; Sage EH
Cancer Res; 2003 Sep; 63(17):5376-80. PubMed ID: 14500371
[TBL] [Abstract][Full Text] [Related]
26. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma.
Maroni P; Matteucci E; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
Breast Cancer Res Treat; 2011 Sep; 129(2):433-50. PubMed ID: 21069452
[TBL] [Abstract][Full Text] [Related]
27. Role of SPARC in bone remodeling and cancer-related bone metastasis.
Ribeiro N; Sousa SR; Brekken RA; Monteiro FJ
J Cell Biochem; 2014 Jan; 115(1):17-26. PubMed ID: 24038053
[TBL] [Abstract][Full Text] [Related]
28. Importance of serum IL-18 and RANTES as markers for breast carcinoma progression.
Eissa SA; Zaki SA; El-Maghraby SM; Kadry DY
J Egypt Natl Canc Inst; 2005 Mar; 17(1):51-5. PubMed ID: 16353083
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of Endothelin-A-receptor in breast cancer: regulation by estradiol and cobalt-chloride induced hypoxia.
Wülfing P; Götte M; Sonntag B; Kersting C; Schmidt H; Wülfing C; Buerger H; Greb R; Böcker W; Kiesel L
Int J Oncol; 2005 Apr; 26(4):951-60. PubMed ID: 15753989
[TBL] [Abstract][Full Text] [Related]
30. The role of SPARC expression in pancreatic cancer progression and patient survival.
Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
[TBL] [Abstract][Full Text] [Related]
31. Cell and Signal Components of the Microenvironment of Bone Metastasis Are Affected by Hypoxia.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187355
[TBL] [Abstract][Full Text] [Related]
32. Humoral SPARC/osteonectin protein in plasma cell dyscrasias.
Turk N; Kusec R; Jaksic B; Turk Z
Ann Hematol; 2005 May; 84(5):304-10. PubMed ID: 15645230
[TBL] [Abstract][Full Text] [Related]
33. Expression profile of endothelin 1 and its receptor endothelin receptor A in papillary thyroid carcinoma and their correlations with clinicopathologic characteristics.
Irani S; Salajegheh A; Gopalan V; Smith RA; Lam AK
Ann Diagn Pathol; 2014 Apr; 18(2):43-8. PubMed ID: 24332749
[TBL] [Abstract][Full Text] [Related]
34. Optimal surveillance for postoperative metastasis in breast cancer patients.
Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
[TBL] [Abstract][Full Text] [Related]
35. Expression and clinical significance of SPARC in clinical stage II tongue squamous cell carcinoma.
Zhang J; Zhang Q; Zhang Q; Liu XK; Li CQ; Guo ZM
Ai Zheng; 2009 Jan; 28(1):68-71. PubMed ID: 19448421
[TBL] [Abstract][Full Text] [Related]
36. Expression of endothelin-1 and endothelin-A and -B receptors in invasive bladder cancer.
Wülfing C; Eltze E; Piechota H; Abol-Enein H; Wülfing P; Bode ME; Hertle L; Sievert KD
Oncol Rep; 2005 Feb; 13(2):223-8. PubMed ID: 15643502
[TBL] [Abstract][Full Text] [Related]
37. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
38. SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.
Kaleağasıoğlu F; Berger MR
World J Gastroenterol; 2014 Oct; 20(40):14747-59. PubMed ID: 25356037
[TBL] [Abstract][Full Text] [Related]
39. [Effects of comprehensive therapy on serum SPARC levels in ankylosing spondylitis patients accompanied with osteoporosis].
Xu JR; Lin Y; Zhang CY; Li WM; Guo CJ; Ye L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Apr; 33(4):466-70. PubMed ID: 23841264
[TBL] [Abstract][Full Text] [Related]
40. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
